-
公开(公告)号:EP1594527A2
公开(公告)日:2005-11-16
申请号:EP04708229.2
申请日:2004-02-04
申请人: LUDWIG INSTITUTE FOR CANCER RESEARCH , Licentia, Ltd. , Flanders Interuniversity Institute for Biotechnology (VIB)
发明人: ALITALO, Kari,University of Helsinki , ERIKSSON, Ulf,Ludwig Inst. for Cancer Research , CARMELIET, Peter,C. for Transgene Tech. & Gene T. , LI, Xuri,c/o Ludwig Institute for Cancer Research , COLLEN, Desire,C. for Transgene Tech. & Gene T. , YLA-HERTTUALA, Seppo,University of Kuopio , SALVEN, Petri,University of Helsinki , RAJANTIE, Iiro,c/o University of Helsinki
CPC分类号: A61K38/193 , A61K35/545 , A61K38/18 , A61K38/1858 , A61K38/1866 , A61K38/202 , A61K48/00 , A61K48/005 , C12N15/86 , C12N2710/10343 , A61K2300/00
摘要: The present invention provides materials and methods for VEGF-B and PDGF therapy, especially therapy directed at stem cell recruitment, proliferation, and/or differentiation.